Veelgestelde vragen

Yes. For international patients this is the first step. You can receive an online preliminary assessment by digitally sharing your contrast-enhanced MRI and any pathology reports via WhatsApp (+90 533 075 72 94). This opinion helps you understand whether traveling to Turkey is meaningful for your situation.

No. For many patients a remote second opinion alone is sufficient and no travel is needed; some tumors are managed with observation or non-surgical treatment. We invite you for in-person evaluation and treatment only if surgery is genuinely appropriate and necessary.

Depending on the brain tumor type, a hospital stay of 3-7 days after surgery is usually followed by a few more days for follow-up and fitness-to-fly clearance; the exact duration is shared in advance based on your tumor. Communication is conducted multilingually and kept clear throughout.

Yes. At discharge a written medical summary including your pathology result, the procedure performed and the recommended next steps is prepared; if needed, radiotherapy or chemotherapy can be coordinated with your team back home. Our aim is for treatment to continue without interruption after Turkey.

Yes. For international patients this is the first step. You can receive an online preliminary assessment by sharing your CTA, MRA or DSA images and reports via WhatsApp (+90 533 075 72 94). This opinion helps you understand whether observation or treatment comes to the fore and whether traveling to Turkey is meaningful.

No. Most aneurysms never rupture and remain unnoticed; in small aneurysms the annual rupture risk is quite low. Many patients are managed with regular MRA follow-up and risk-factor control alone. We invite you to Turkey for treatment only if intervention is genuinely necessary.

Both are effective methods with a 90-95% success rate reported in the literature; the 'better' one is the one most suited to your aneurysm. Coiling is less invasive with quick recovery but carries a risk of reopening; clipping offers a permanent solution but requires a craniotomy. The decision is made together after your images are assessed.

After coiling a stay of a few days is usually expected, and after clipping somewhat longer; additional days for follow-up and fitness-to-fly clearance are added. The exact duration is shared in advance according to the method and your condition, and communication is conducted multilingually.

Yes. For international patients this is the first step. You can receive an online preliminary assessment by sharing your existing MRI images and, if NPH is suspected, a short walking video via WhatsApp (+90 533 075 72 94). This opinion helps you understand the type of hydrocephalus and whether traveling to Turkey is meaningful.

A shunt transfers excess CSF to the abdominal cavity through a permanent tube-valve system and usually remains for life; it comes to the fore in communicating hydrocephalus and NPH. ETV creates an opening in the floor of the ventricle, leaves no foreign body in the body and is preferred in suitable obstructive cases. Which is suitable is determined by the type of hydrocephalus and your MRI.

ETV usually involves a 1-2 day stay and a shunt a few days; additional days for follow-up and fitness-to-fly clearance are added. A written medical summary is prepared at discharge; if a programmable valve is used, valve-setting coordination with your team back home can be planned.

NPH is a treatable condition, and with a shunt a significant proportion of patients are reported to have meaningful improvement in gait and cognitive function; however, the same degree of success cannot be guaranteed in every patient. A 'tap test' can be performed to predict the chance of success. Sharing a walking video and a recent MRI remotely makes the assessment easier.

Yes. For international patients this is the first step. You can receive an online preliminary assessment by sharing your contrast-enhanced MRI and any CT images via WhatsApp (+90 533 075 72 94). This opinion helps you understand whether observation or treatment comes to the fore and whether traveling to Turkey is meaningful.

Often no. A small, asymptomatic, slow-growing meningioma—especially in older patients—can be managed with remotely coordinated periodic MRI follow-up. We invite you for treatment with surgery or Gamma Knife only if the tumor grows, causes symptoms or compresses.

In some patients, yes. For deep-seated, surgically high-risk or small-to-moderate meningiomas, stereotactic radiosurgery (Gamma Knife, CyberKnife) is an effective option; for large, symptomatic tumors surgery comes to the fore. Which method is suitable is determined by the MRI you share remotely and multidisciplinary evaluation.

Usually a few days of hospital stay after surgery is followed by a few more days for follow-up and fitness-to-fly clearance; the exact duration is shared in advance according to the tumor's location and size. Communication is conducted multilingually, and a written summary is provided for follow-up in your home country.

Yes, and because speed matters in glioblastoma this is the first step. You can obtain an online opinion without delay by sharing your contrast-enhanced MRI and any pathology-molecular results via WhatsApp (+90 533 075 72 94). This opinion helps you understand the suitability of surgery and whether traveling to Turkey is meaningful.

Because glioblastoma infiltrates the surrounding brain microscopically, surgery alone does not provide a 'cure'; radiotherapy and chemotherapy (the Stupp protocol) follow the operation. The aim of treatment is to control the disease and preserve quality of life. No outcome can be guaranteed, and expectations are shared honestly.

For most patients, yes. Because the Stupp protocol is an international standard, at discharge your pathology-molecular results and the recommended protocol are provided in writing; this enables uninterrupted coordination with the oncology team in your home country. The process is planned with this continuity in mind from the start.

In glioblastoma a few days of hospital stay after surgery is usually followed by a few more days for follow-up and fitness-to-fly clearance; the exact duration is shared in advance according to the tumor's location and your condition. Communication is conducted multilingually, and continuation treatment is coordinated with a written summary.

Yes. For international patients this is the first step. You can receive an online preliminary assessment by sharing your brain MRI and the reports/pathology-molecular results of your primary cancer via WhatsApp (+90 533 075 72 94). This opinion helps you understand whether local treatment comes to the fore and whether traveling to Turkey is meaningful.

Either may be right depending on the situation. For a single, large, symptomatic lesion, surgery comes to the fore; for small-to-moderate or a few lesions, Gamma Knife is preferred. For multiple widespread metastases, Gamma Knife or whole-brain radiotherapy comes into consideration. The decision is made multidisciplinarily according to the number, size and location of metastases and the primary cancer.

For most patients, yes. Local treatment (surgery/Gamma Knife) is usually done in Turkey, while systemic treatment (chemotherapy, targeted drugs, immunotherapy) is coordinated with the oncology team in your home country. A written medical summary is provided at discharge; the plan is built with this continuity in mind from the start.

It depends on the local treatment (surgery or radiosurgery); for surgery a few days of hospital stay is usually followed by additional days for follow-up and fitness-to-fly clearance. The exact duration is shared in advance according to your situation, and communication is conducted multilingually.

Yes. For international patients this is the first step. You can receive an online preliminary assessment by sharing your MRI images and any pathology-molecular results (IDH status matters) via WhatsApp (+90 533 075 72 94). This opinion helps you understand the suitability of surgery and whether traveling to Turkey is meaningful.

No. With the 2021 WHO classification, IDH-mutant astrocytoma and IDH-wildtype glioblastoma are considered distinct diseases; IDH-mutant astrocytomas carry a markedly better prognosis. The true type and grade of the tumor become clear with pathological and molecular examination of tissue obtained at surgery or biopsy. This is why sharing your molecular results strengthens the assessment.

The goal is the widest possible resection while preserving function. If the tumor is close to critical areas such as speech or movement, functional mapping and, when needed, awake craniotomy are used, and the resection margin is set accordingly to reduce the risk of permanent loss. The risks are discussed openly in the remote opinion and before surgery.

For most patients, yes. Surgery is done in Turkey; any required radiotherapy/chemotherapy or treatments such as an IDH inhibitor can be coordinated with the oncology team in your home country. At discharge your pathology-molecular results and the recommended plan are provided in writing, so treatment continues without interruption.

Yes. For international patients this is the first step. You can receive an online preliminary assessment by sharing your MRI images and any pathology-molecular results (IDH and 1p/19q matter) via WhatsApp (+90 533 075 72 94). This opinion helps you understand the correct subtype, the suitability of surgery and whether traveling to Turkey is meaningful.

Tissue is required for a definitive diagnosis: under the 2021 WHO classification, both an IDH mutation and 1p/19q co-deletion must be demonstrated. This tissue is obtained by surgical resection or stereotactic biopsy. In most cases, the widest safe resection provides both treatment and an accurate molecular diagnosis; if tissue was already taken in your home country, you can share the results remotely.

Oligodendroglioma has the most favorable prognosis among diffuse gliomas and is sensitive to radiotherapy-chemotherapy, but because it is a diffuse tumor it is not correct to call it 'benign'. Prognosis varies with grade, extent of resection and molecular features; close follow-up is recommended. No outcome can be guaranteed, and expectations are shared honestly.

For most patients, yes. Surgery is done in Turkey; any required radiotherapy/chemotherapy (such as PCV) or treatments like an IDH inhibitor can be coordinated with the oncology team in your home country. At discharge your pathology-molecular results and the recommended plan are provided in writing, so treatment continues without interruption.

Yes. For international patients this is the first step. You can receive an online preliminary assessment by digitally sharing your brain MRI, EEG/video-EEG reports and medication list via WhatsApp (+90 533 075 72 94). This opinion helps you understand whether surgery is an option for you and whether traveling to Turkey is meaningful.

No. Surgery is appropriate mainly for patients whose seizures persist despite trials of at least two suitable medications (drug-resistant) and whose seizure focus can be safely located and removed. Many patients are managed with medication. Who is a candidate becomes clear after imaging and EEG evaluation.

The duration depends on the advanced tests required (for example, video-EEG monitoring may take several days) and the type of surgery; a few days of stay after surgery is usually expected and the exact duration is shared in advance. Communication is conducted multilingually and kept clear throughout.

Yes. At discharge a written medical summary including the procedure performed, the medication plan and the recommended neurology follow-up is prepared; antiepileptic treatment and seizure follow-up can be coordinated with your team back home. Our aim is for treatment to continue without interruption after Turkey.

Yes. You can receive an online preliminary assessment by digitally sharing your thin-slice brain MRI and your medication list via WhatsApp (+90 533 075 72 94). This opinion helps you understand whether the diagnosis is consistent with trigeminal neuralgia and which treatment options might suit you.

No. The first treatment is usually medication, which controls the pain for a long time in many patients. Options such as microvascular decompression, percutaneous procedures or Gamma Knife come into consideration when medication is insufficient. Which one is appropriate is decided together after evaluation.

The duration depends on the chosen method: microvascular decompression may require a few days of stay, while percutaneous procedures and Gamma Knife are usually shorter; the exact duration is shared in advance. Communication is conducted multilingually and kept clear throughout.

In trigeminal neuralgia the pain can recur after a time, and this is discussed openly from the start. At discharge a written summary with the medication plan and follow-up recommendations is provided; if recurrence occurs, a medication adjustment or another option can be coordinated with your team back home.

Yes. You can receive an online preliminary assessment by digitally sharing your contrast-enhanced thin-slice brain MRI and, if available, your hearing test (audiogram) via WhatsApp (+90 533 075 72 94). This opinion helps you understand whether observation, radiosurgery or surgery comes into consideration and whether traveling to Turkey is meaningful.

No. The tumor is mostly benign and grows slowly; for small, asymptomatic tumors, observation with serial MRI is a valid option. For medium-sized tumors Gamma Knife comes to the fore, and for large tumors or those compressing the brainstem surgery does. Which one is appropriate is decided together after evaluation.

Preserving hearing is the aim, but it cannot be guaranteed; the chance is higher when the tumor is small and decreases as it grows, and it depends on the chosen method. For this reason your hearing status is evaluated from the start and expectations are discussed openly.

The duration depends on the chosen method: Gamma Knife is usually completed with a short stay, while microsurgery requires a few days of stay; the exact duration is shared in advance. Communication is conducted multilingually and kept clear throughout.

Yes. You can receive an online preliminary assessment by digitally sharing your pituitary-protocol brain MRI, your hormone blood tests and, if available, your visual field results via WhatsApp (+90 533 075 72 94). This opinion helps you understand whether treatment should be surgery, medication or observation, and whether traveling to Turkey is meaningful.

No. In prolactin-secreting adenomas the first treatment is usually medication; in small, asymptomatic adenomas observation may be sufficient. Surgery comes to the fore in adenomas that affect vision, grow, or cause hormone excess (acromegaly, Cushing's). The right path is determined together after evaluation.

No, in most cases the skull is not opened; endoscopic transnasal-transsphenoidal surgery, reaching the tumor through the nose, is preferred and there is no external incision. Only some large or extended adenomas may require a different approach; this would be explained to you in advance.

Endoscopic pituitary surgery usually involves a few days of stay followed by a few more days for follow-up; the exact duration is shared in advance. Hormone follow-up can be coordinated with your endocrinology team back home. Communication is conducted multilingually and kept clear throughout.

Yes. You can receive an online preliminary assessment by digitally sharing your brain MRI including cavernoma-sensitive sequences (SWI/GRE) and any prior imaging via WhatsApp (+90 533 075 72 94). This opinion helps you understand whether observation or surgery comes into consideration and whether traveling to Turkey is meaningful.

No. In asymptomatic, incidentally found cavernomas the right approach is most often observation with serial MRI. Surgery comes to the fore if there is bleeding, drug-resistant seizures, progressive symptoms or a safely accessible location. The decision is made together after evaluation.

It can, but surgery carries a markedly higher risk in the brainstem and deep locations; in these cases the decision is made far more carefully, with the benefit-risk balance discussed in detail. In some situations observation may be safer, and we discuss this openly.

If surgery is performed, a few days of stay followed by a few more days for follow-up is usually expected; the exact duration is shared in advance based on the cavernoma's location and type. Seizure/neurology follow-up can be coordinated with your team back home. Communication is conducted multilingually and kept clear throughout.